Embed this press release by copying the code below:
IRB Approves CITrials' Sites for Roche's Schizophrenia Program on Novel Antipsychotic Medication
IRB Approves CITrials' Sites for Roche's Schizophrenia Program on Novel Antipsychotic Medication